✦ LIBER ✦

PP43. Quality of life assessments of patients with non-small cell lung cancer receiving gemcitabine (Gemzar™) and cisplatin

✍ Scribed by A Anton; A Carrato; JL Gonzalez-Larriba; C Vadel; B Masutti; J Montalar; E Aranda; AM Liepa

Book ID: 117665321
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 158 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)85956-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

43 Prognostic value of performance statu

43 Prognostic value of performance status (PS) in advanced non-small cell lung cancer (NSCLC) patients receiving gemcitabine and cisplatin

✍ Gaafar, R.; Sallam, Y.; Khaled, H.; Mansour, O.; Abdel-Karim, N.; El-Attar, I. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Improvement of quality of life with Shen

Improvement of quality of life with Shenfu injection in non small cell lung cancer patients treated with gemcitabine plus cisplatin regimen

✍ Wu Wan-yin; Long Shun-qin; Zhang Hai-bo; Chai Xiao-shu; Deng Hong; Xue Xiao-guan 📂 Article 📅 2006 🏛 Chinese Association of Traditional and Western Med 🌐 English ⚖ 397 KB

Treatment of advanced non-small cell lun

Treatment of advanced non-small cell lung cancer with gemcitabine and cisplatin

✍ Almodovar, M; Dionisio, J; Matias, D; Duro da Costa, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Improving quality of life in patients wi

Improving quality of life in patients with non-small cell lung cancer: Research experience with gemcitabine

✍ N. Thatcher; P. Hopwood; H. Anderson 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 531 KB

Pharmacology of the paclitaxel–cisplatin

Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

29 Results of independent review of 374

29 Results of independent review of 374 patients with non-small cell lung cancer (NSCLC) treated with gemcitabine (Gemzar®)

✍ Gwyther, S.J.; Aapro, M.S.; Hatty, S.R.; Postmus, P.E.; Smith, I.E. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 128 KB